Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jörg Schlaak

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Zeitschrift Fur Rheumatologie|March 8, 2022
[Cryoglobulinemic vasculitis]Christof Specker, Denise Passens, Jörg Schlaak
Virology|December 10, 2008
Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expressionZhongji Meng, Song Qiu, Xiaoyong Zhang, et al.
Journal of Hepatology|May 1, 2014
KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugsChristine Thoens, Christoph Berger, Martin Trippler, et al.
Digestive Diseases and Sciences|November 19, 2015
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in GermanyJörg Petersen, Renate Heyne, Stefan Mauss, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Zeitschrift Fur Rheumatologie|March 8, 2022
[Cryoglobulinemic vasculitis]Christof Specker, Denise Passens, Jörg Schlaak
Virology|December 10, 2008
Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expressionZhongji Meng, Song Qiu, Xiaoyong Zhang, et al.
Journal of Hepatology|May 1, 2014
KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugsChristine Thoens, Christoph Berger, Martin Trippler, et al.
Digestive Diseases and Sciences|November 19, 2015
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in GermanyJörg Petersen, Renate Heyne, Stefan Mauss, et al.
Pageof 1